SUNNYVALE, Calif. , Dec. 6, 2012 /PRNewswire/ -- Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that it will be presenting at the OneMedForum 2013 healthcare conference on Tuesday, January 8 ^th , 2013 at 2pm Pacific . OneMedForum 2013 will be held at the Sir Francis Drake Hotel during the week of the J.P. Morgan 31 ^st Annual Healthcare Conference in San Francisco . A link to the live webcast of the presentation will be made available to the public prior to the conference.